AFJK Financials Aimei Health Technology Co., Ltd.
2 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →
Key annual figures
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | — | $1M | — | — | -26.1% | 8.8% | — | — | — |
| 2024 | — | $3M | — | — | -172.8% | 3.5% | — | — | — |
Key quarterly figures
| Quarter | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| Jun '26 | — | -$83144 | — | — | 1.9% | -0.7% | — | — | — |
| Mar '26 | — | $45440 | — | — | -1.1% | 0.4% | — | — | — |
| Dec '25 | — | $98117 | — | — | -2.4% | 0.8% | — | — | — |
| Sep '25 | — | $352019 | — | — | -10.2% | 0.8% | — | — | — |
| Jun '25 | — | $424970 | — | — | -14.9% | 1.0% | — | — | — |
| Mar '25 | — | $184662 | — | — | -7.8% | 0.4% | — | — | — |
| Dec '24 | — | $444113 | — | — | -30.1% | 0.6% | — | — | — |
| Sep '24 | — | $743510 | — | — | -93.3% | 1.0% | — | — | — |
| Jun '24 | — | $609092 | — | — | -102.0% | 0.8% | — | — | — |
| Mar '24 | — | $755500 | — | — | -262.5% | 1.1% | — | — | — |
| Dec '23 | — | $175007 | — | — | -130.5% | 0.2% | — | — | — |
| Sep '23 | — | $0 | — | — | 0.0% | — | — | — | — |
| Jun '23 | — | -$3618 | — | — | 100.0% | — | — | — | — |
Valuation over time
How the market has priced AFJK against its own fundamentals since 2024-01 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.
- The price-to-earnings ratio has risen from 13.2× (Dec '24) to 36.6× (Sep '26).
Frequently asked questions
Is AFJK growing its revenue and profit?
See the revenue and net-income charts above for Aimei Health Technology Co., Ltd.'s multi-year trend.
How much debt does AFJK have?
As of FY2025, Aimei Health Technology Co., Ltd. reported — of total debt against — of cash.
What is AFJK's profit margin?
In FY2025, gross margin was —, operating margin —, and net margin —.
What is AFJK's P/E ratio?
As of Sep '26, Aimei Health Technology Co., Ltd. traded at a price-to-earnings ratio of about 36.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.